<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-3347</journal-id>
<journal-title><![CDATA[Colombian Journal of Anestesiology]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. anestesiol.]]></abbrev-journal-title>
<issn>0120-3347</issn>
<publisher>
<publisher-name><![CDATA[SCARE-Sociedad Colombiana de Anestesiología y Reanimación]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-33472025000300007</article-id>
<article-id pub-id-type="doi">10.5554/22562087.e1147</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Droperidol versus haloperidol on postoperative nausea and vomiting: a retrospective analysis]]></article-title>
<article-title xml:lang="es"><![CDATA[Droperidol versus haloperidol en náuseas y vómito posoperatorios: un análisis retrospectivo]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[Maia C]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ajayi]]></surname>
<given-names><![CDATA[Omolola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Naranjo]]></surname>
<given-names><![CDATA[Julian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[McGrew]]></surname>
<given-names><![CDATA[Yvette N. Martin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[Darrell R]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sprung]]></surname>
<given-names><![CDATA[Juraj]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Weingarten]]></surname>
<given-names><![CDATA[Toby N]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Mayo Clinic Alix School of Medicine  ]]></institution>
<addr-line><![CDATA[Jacksonville Florida]]></addr-line>
<country>USA</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Georgetown University School of Medicine  ]]></institution>
<addr-line><![CDATA[Washington DC]]></addr-line>
<country>USA</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Mayo Clinic College of Medicine and Science Department of Anesthesiology and Perioperative Medicine ]]></institution>
<addr-line><![CDATA[Rochester Minnesota]]></addr-line>
<country>USA</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Mayo Clinic College of Medicine and Science Division of Biomedical Statistics and Informatics Health Sciences Research]]></institution>
<addr-line><![CDATA[Rochester Minnesota]]></addr-line>
<country>USA</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2025</year>
</pub-date>
<volume>53</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-33472025000300007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-33472025000300007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-33472025000300007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction Butyrophenones are effective prophylactic drugs against postoperative nausea and vomiting (PONV). Our practice used droperidol for PONV prophylaxis until supply chain issues in 2020 required a substitution to haloperidol.  Objective To compare the use of these two butyrophenones and their association with the magnitude of reduction PONV and sedation during admission to postanesthesia care unit (PACU).  Methods Retrospective review of the records of adult surgical patients administered a butyrophenone and admitted to the PACU, from May 2018 through December 2022. PONV was defined as administration of rescue antiemetics during PACU admission. Inverse probability of treatment weighing (IPTW) analysis was performed using generalized estimating equations with robust variance estimates to assess the effects of droperidol and haloperidol on PONV rate.  Results We identified 905 (2018 - 2020) and 651 patients (2020 - 2022) receiving droperidol or haloperidol, respectively. The IPTW PONV rate was 75 (8.3%) for droperidol and 84 (12.9%) haloperidol (odds ratio 0.60; 95% confidence interval 0.41 to 0.87, for the use of droperidol vs haloperidol). Moderate or higher levels of sedation (Richmond Agitation Sedation Scale score &lt; -3) was noted in 163 (18.0) of droperidol and 102 (15.7%) of haloperidol patients, which was nonsignificant, P0.222, following IPTW adjustment, P0.269. Median [interquartile range] PACU length of stay was comparable for two butyrophenones, 70 [51, 99] vs. 68 [48, 105] minutes for droperidol vs haloperidol, respectively, P0.647.  Conclusions Droperidol was associated with lower rates of PONV during PACU admission than haloperidol, but the rate of sedation was higher.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: Las butirofenonas son medicamentos profilácticos efectivos contra las náuseas y el vómito posoperatorios (NVPO). En la práctica de los autores de este artículo utilizaron droperidol para la profilaxis de NVPO hasta que los problemas de la cadena de suministro en 2020 requirieron una sustitución por haloperidol.  Objetivo: Comparar el uso de estas dos butirofenonas y su asociación con la magnitud de la reducción de NVPO y la sedación durante la admisión a la unidad de cuidados posanestésicos (UCPA).  Métodos: Revisión retrospectiva de los registros de pacientes quirúrgicos adultos a los que se les administró una butirofenona y fueron admitidos en la UCPA entre mayo de 2018 y diciembre de 2022. La presencia de NVPO se definió como condición para administrar antieméticos de rescate durante la admisión a la UCPA. Se realizó un análisis de ponderación de probabilidad inversa de tratamiento (IPTW, por sus siglas en inglés) utilizando ecuaciones de estimación generalizadas con estimaciones de varianza robusta para evaluar los efectos de droperidol y haloperidol en la tasa de NVPO.  Resultados: Se identificaron 905 pacientes (2018-2020) y 651 pacientes (2020-2022) que recibieron droperidol o haloperidol, respectivamente. La tasa de NVPO IPTW fue de 75 (8,3%) para droperidol y 84 (12,9%) para haloperidol (razón de probabilidades 0,60; intervalo de confianza del 95% [0,41-0,87], para el uso de droperidol vs. haloperidol). Se observaron niveles moderados o superiores de sedación (escala de sedación/agitación de Richmond &lt; -3) en 163 (18,0%) de los pacientes con droperidol y 102 (15,7%) de los pacientes con haloperidol, lo cual no fue significativo, p=0,222, después del ajuste IPTW, p=0,269. La mediana [rango intercuartílico] de la duración de la estancia en la UCPA fue comparable para las dos butirofenonas, 70 [51, 99] vs. 68 [48, 105] minutos para droperidol vs. haloperidol, respectivamente, p=0,647.  Conclusiones: El droperidol se asoció con tasas más bajas de NVPO durante la admisión a la UCPA que el haloperidol, pero la tasa de sedación fue mayor.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Droperidol]]></kwd>
<kwd lng="en"><![CDATA[Haloperidol]]></kwd>
<kwd lng="en"><![CDATA[Antiemetic]]></kwd>
<kwd lng="en"><![CDATA[General anesthesia]]></kwd>
<kwd lng="en"><![CDATA[Comparison]]></kwd>
<kwd lng="es"><![CDATA[Droperidol]]></kwd>
<kwd lng="es"><![CDATA[Haloperidol]]></kwd>
<kwd lng="es"><![CDATA[Antiemético]]></kwd>
<kwd lng="es"><![CDATA[Anestesia general]]></kwd>
<kwd lng="es"><![CDATA[Comparación]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKeage]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wagstaff]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intravenous droperidol: a review of its use in the management of posoperative nausea and vomiting]]></article-title>
<source><![CDATA[Drugs]]></source>
<year>2006</year>
<volume>66</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>2123-47</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gan]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Belani]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Bergese]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Diemunsch]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Habib]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fourth Consensus Guidelines for the Management of Posoperative Nausea and Vomiting]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>2020</year>
<volume>131</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>411-48</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Habib]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Gan]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>2003</year>
<volume>96</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1377-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacoby]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Fulton]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cesta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Heller]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[After the black box warning: dramatic changes in ED use of droperidol]]></article-title>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2005</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>196</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuttall]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Eckerman]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Pawlaski]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Wigersma]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Marienau]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2007</year>
<volume>107</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>531-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuttall]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Malone]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Michels]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Trudell]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Renk]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
<name>
<surname><![CDATA[Marienau]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2013</year>
<volume>118</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>382-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weingarten]]></surname>
<given-names><![CDATA[TN]]></given-names>
</name>
<name>
<surname><![CDATA[Bergan]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Narr]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Sprung]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of changes in intraoperative management on recovery from anesthesia: a review of practice improvement initiative]]></article-title>
<source><![CDATA[BMC Anesthesiol]]></source>
<year>2015</year>
<volume>15</volume>
<page-range>54</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuttall]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Pham Louis]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Oyen]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Marsland]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Ackerman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The incidence of torsades de pointes with perioperative triple antiemetic administration]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2024</year>
<volume>58</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>906-11</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sessler]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Gosnell]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Grap]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Brophy]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[O'Neal]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
<name>
<surname><![CDATA[Keane]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2002</year>
<volume>166</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1338-44</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aldrete]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The post-anesthesia recovery score revisited]]></article-title>
<source><![CDATA[J Clin Anesth]]></source>
<year>1995</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>89-91</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Habib]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Gan]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Haloperidol for posoperative nausea and vomiting: are we reinventing the wheel?]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>2008</year>
<volume>106</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1343-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Shieh]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Tzeng]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-dose haloperidol prevents post-operative nausea and vomiting after ambulatory laparoscopic surgery]]></article-title>
<source><![CDATA[Acta Anaesthesiol Scand]]></source>
<year>2008</year>
<volume>52</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>280-4</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chu]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Shieh]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Tzeng]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prophylactic effect of haloperidol plus dexamethasone on posoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>2008</year>
<volume>106</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1402-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Sheehan]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Reddan]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence- based review of the black-box warning for droperidol]]></article-title>
<source><![CDATA[Am J Health Syst Pharm]]></source>
<year>2007</year>
<volume>64</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1174-86</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Administration]]></surname>
<given-names><![CDATA[UFD]]></given-names>
</name>
</person-group>
<source><![CDATA[Highlights of prescribing information: Haldol]]></source>
<year>2005</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Administration]]></surname>
<given-names><![CDATA[UFD]]></given-names>
</name>
</person-group>
<source><![CDATA[Highlights of prescribing information: Ondansetron]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuttall]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Voogd]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Danke]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Warner]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Oyen]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Marienau]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The incidence of torsades de pointes with peri-operative low-dose ondansetron administration]]></article-title>
<source><![CDATA[Pharmacotherapy]]></source>
<year>2022</year>
<volume>42</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>292-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Apfel]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Laara]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Koivuranta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Greim]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Roewer]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A simplified risk score for predicting posoperative nausea and vomiting: conclusions from cross-validations between two centers]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>1999</year>
<volume>91</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>693-700</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
